Join Meeting Now

Your data is secure and never shared.

Australia
August 2026

Australia Medical Thermometer Market Size, Share & Forecast, By Product Type, Care Setting & Technology, 2025–2032

2032

The Australia Medical Thermometer Market worth USD 72 million in 2025 is growing at a CAGR of 6.24% to reach USD 103 million by 2031. Helen of Troy Limited, Omron Healthcare Co., Ltd., Baxter International Inc., Microlife AG and Royal Philips are the major companies operating in this market.

Report Details

Base Year

2025

Pages

89

Region

Australia

Author

Ken Research

Product Code
KR-RPT-V02-02731

CHAPTER 1 - MARKET SUMMARY

Market Overview

The Australia Medical Thermometer Market serves home users, hospitals, primary-care practices, aged-care facilities and other clinical environments requiring rapid fever assessment and patient monitoring. Australia's population reached 27.6 million in June 2025, while people aged 65 and over accounted for approximately 18% of the population, expanding the recurring need for temperature monitoring across acute and chronic-care pathways.

Demand is geographically concentrated in Australia's largest population and healthcare hubs. New South Wales had 8.64 million residents at December 2025, ahead of Victoria at 7.12 million and Queensland at 5.71 million. The concentration of households, hospitals, pharmacies and general practices in these states gives suppliers greater distribution density and supports stronger turnover for consumer and professional thermometry products.

Market Value

USD 72 million

2025

Dominant Region

New South Wales

Dominant Segment

Infrared Forehead and Ear Thermometers

fastest growing

Total Number of Players

45

Future Outlook

The Australia Medical Thermometer Market is expected to transition from the post-pandemic normalisation cycle into structurally positive expansion through 2032. Following an estimated historical CAGR of -4.36% during 2020-2025, the market is projected to grow at 6.24% during 2025-2032. Revenue is expected to reach approximately USD 103 million in 2031 and USD 110 million by 2032. The forecast reflects population growth, an ageing patient base, recurring respiratory disease surveillance, healthcare utilisation and replacement of low-value contact thermometers with higher-value infrared, institutional and digitally connected products.

Product mix is expected to become more important than headline unit growth. Market volume is projected to increase from approximately 4.08 million units in 2025 to 5.38 million units in 2032, while the blended realised value per unit rises as ear, forehead, connected and professional clinical devices capture a larger revenue share. Hospital procurement, aged care and premium family-health channels should produce comparatively resilient demand, while pharmacy and e-commerce channels remain critical to consumer replacement purchases. Regulatory compliance and supplier quality will continue separating established brands from low-cost commodity entrants.

6.24%

Forecast CAGR

$110 Mn

2030 Projection

Base Year

2025

Historical Period

2020-2025

Forecast Period

2025-2032

Historical CAGR

-4.36%

CHAPTER 2 - SCOPE OF REPORT

Scope of the Market

Click to Explore Interactive Mind Map

CHAPTER 3 - Key Stakeholders

Key Target Audience

Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning.

Investors

CAGR, premiumisation, import exposure, margins, competitive concentration, exits

Corporates

pricing, channel coverage, sourcing, registration, portfolio mix, partnerships

Government

device safety, ARTG compliance, resilience, ageing, procurement, access

Operators

inventory, accuracy, clinical workflows, consumables, procurement, service levels

Financial institutions

working capital, import risk, cash flow, margins, covenants

What You'll Gain

  • Market sizing and trajectory
  • Policy and compliance mapping
  • Trade exposure indicators
  • Segment structure and levers
  • Competitive landscape shortlist
  • CEO-grade risk priorities

80+

Pages of insights

CHAPTER 4 - Market Size & Growth

Market Size, Growth Forecast and Trends

This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers.

Historical & Projected Market Size ($ Million)

Year-over-Year Growth Rate (%)

Market Value vs Volume Growth (%)

Historical Market Performance (2020-2025)

The market peaked during pandemic-era fever-screening and household stock-up cycles, reaching an estimated USD 98 million in 2021 before correcting sharply through 2023. External trade data support this normalisation pattern: 2022 HS 902519 imports were approximately USD 58.5 million, falling to USD 50.3 million in 2023 before recovering to USD 56.1 million in 2024. The 2024-2025 recovery indicates that underlying clinical and household replacement demand has re-emerged after pandemic inventories were absorbed.

Forecast Market Outlook (2025-2032)

From 2025, value growth is expected to exceed unit growth as product mix shifts toward non-contact infrared, tympanic and connected professional devices. Market value is projected to reach USD 110 million by 2032, representing a 6.24% CAGR, while unit volumes increase to approximately 5.38 million. Ageing demographics, healthcare utilisation and replacement cycles provide the demand base, while mandatory product registration and safety requirements support a gradual shift toward branded, compliant and higher-value offerings rather than unregistered commodity supply.

CHAPTER 5 - Market Data

Market Breakdown

The Australia Medical Thermometer Market is moving from pandemic-driven volume volatility toward steady replacement-led growth. For CEOs and investors, the most relevant economics are unit demand, realised price per device and dependence on imported supply.

Market Breakdown

Historical Data (2020-2024) • Base Data (2025) • Forecast Data (2026-2032)

Year
Market Size (USD Mn)
YoY Growth (%)
Units Sold (Mn)
Blended ASP (USD/unit)
Import Dependence (%)
Period
2020$90 Mn+-5.8015.52
$#%
Forecast
2021$98 Mn+8.89%6.3015.56
$#%
Forecast
2022$76 Mn+-22.45%5.1014.90
$#%
Forecast
2023$65 Mn+-14.47%3.7017.57
$#%
Forecast
2024$69 Mn+6.15%3.9517.47
$#%
Forecast
2025$72 Mn+4.35%4.0817.65
$#%
Forecast
2026$76 Mn+5.56%4.2317.97
$#%
Forecast
2027$81 Mn+6.58%4.3918.45
$#%
Forecast
2028$86 Mn+6.17%4.5618.86
$#%
Forecast
2029$91 Mn+5.81%4.7419.20
$#%
Forecast
2030$97 Mn+6.59%4.9419.64
$#%
Forecast
2031$103 Mn+6.19%5.1520.00
$#%
Forecast
2032$110 Mn+6.80%5.3820.45
$#%
Forecast

Units Sold

9.1 million emergency department presentations, 2024-25, Australia. High patient throughput sustains professional temperature measurement demand across triage and routine vital-sign workflows, supporting recurring replacement and consumables demand.

Blended ASP

18% population aged 65 and over, 2024-25, Australia. Ageing increases care intensity and supports premium clinical, tympanic and connected thermometers, allowing value growth to outpace basic device volumes.

Import Dependence

2.94 million units imported from China, 2024, Australia. China represented roughly three quarters of reported HS 902519 import units, making supplier diversification and inventory resilience commercially important.

CHAPTER 6 - Segmentation

Market Segmentation Framework

Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns.

No of Segments

7

Dominant Segment

Product Type

Fastest Growing Segment

Technology

Product Type

Infrared Forehead Thermometers
$%
Infrared Ear Thermometers
$%
Digital Contact Thermometers
$%
Clinical Continuous and Probe Thermometers
$%

Care Setting

Hospitals and Emergency Departments
$%
General Practice and Primary Care
$%
Aged Care and Long-Term Care
$%
Home and Family Care
$%

End User

Healthcare Professionals
$%
Parents and Caregivers
$%
Older Adults and Chronic-Care Users
$%
Institutional Screening Staff
$%

Disease Area

Respiratory Infections
$%
Pediatric Febrile Illness
$%
Acute and Emergency Care
$%
Perioperative and Inpatient Monitoring
$%

Channel

Community Pharmacy
$%
Hospital and Institutional Procurement
$%
Medical Device Distributors
$%
E-Commerce and Direct-to-Consumer
$%

Technology

Contact Electronic Sensing
$%
Infrared Tympanic Sensing
$%
Non-Contact Forehead Infrared
$%
Connected and App-Enabled Thermometry
$%

Geography

New South Wales
$%
Victoria
$%
Queensland
$%
Western Australia
$%
Remaining States and Territories
$%

Key Segmentation Takeaways

Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns.

Product Type

Product mix is the principal determinant of revenue because unit prices and replacement behaviour differ significantly between basic digital contact products and higher-value infrared or professional thermometry systems. Infrared forehead and ear devices are increasingly favoured where rapid, hygienic measurement is important, while low-cost contact thermometers remain relevant for value-sensitive household and primary-care users.

Technology

Technology is expected to be the fastest-growing analytical dimension as purchasers shift from simple contact measurement toward non-contact infrared, faster professional sensing and connected patient-monitoring workflows. Connected and app-enabled thermometry offers the strongest premiumisation potential because temperature readings can be integrated with broader vital-sign records, remote monitoring and institutional data-management systems.

CHAPTER 7 - Regional Analysis

Regional Analysis

Australia occupies a mid-to-upper position among selected developed Asia-Pacific medical thermometer markets. Its market is smaller than Japan and South Korea but materially larger than New Zealand, while its gross thermometer imports are high relative to population because domestic manufacturing is limited. Singapore's gross import statistics are distorted by substantial re-export activity.

Focus Country Ranking

3rd

Focus Country Market Size

USD 72 Mn (2025)

Australia CAGR (2025-2032)

6.24%

Regional Analysis (Current Year)

Regional Analysis Comparison

MetricSouth KoreaJapanAustraliaSingaporeNew Zealand
Market Size (USD Mn, 2025)205155722212
CAGR (%)5.4%4.7%6.24%5.9%5.6%
Population (Mn, 2025)51.7123.827.66.05.3
Infrared Thermometer Imports (USD Mn, 2024)268.1120.856.196.69.1

Market Position

Australia ranks third within the selected peer set, supported by a 27.6 million population and substantial imported thermometer supply, while Japan and South Korea retain larger addressable healthcare demand bases.

Growth Advantage

Australia's projected 6.24% CAGR is above the modeled Japan rate of 4.7% and South Korea rate of 5.4%, reflecting stronger replacement, population and premium-product mix effects.

Competitive Strengths

Australia combines 9.1 million annual public-hospital emergency presentations, a highly regulated Class IIa device environment and deep pharmacy and primary-care access, favouring compliant branded suppliers.

CHAPTER 8 - INDUSTRY ANALYSIS

Growth Drivers, Challenges & Opportunities

Comprehensive analysis of key factors shaping the Australia Medical Thermometer Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments.

Growth Drivers

Ageing Population and Higher Monitoring Intensity

  • The older population grew by 26% between 2017 and 2025 (Australia), increasing demand across aged care, primary care and home-based management where basic temperature measurement remains a routine clinical indicator.
  • Australia's total population reached 27.6 million at June 2025, adding households and patients to the addressable installed base and supporting replacement sales for family-health thermometers.
  • The national median age reached approximately 38.4 years in 2024-25, reinforcing the long-duration demographic shift toward higher healthcare utilisation and more frequent health monitoring.

High Healthcare Service Utilisation

  • Public hospitals operated 293 purpose-built emergency departments in 2024-25, creating a distributed institutional base for professional thermometry, probe covers, replacements and vital-sign systems.
  • Australia recorded approximately 12.8 million hospitalisations in 2024-25, sustaining use of temperature measurement across admissions, wards, surgery and clinical observation.
  • Non-hospital primary care generated approximately 200.3 million Medicare-subsidised services in 2024-25, giving thermometer suppliers substantial exposure beyond hospitals through GP and community-care workflows.

Infrared and Professional Device Premiumisation

  • Infrared ear and forehead products benefit from rapid measurement and low-contact workflows, while Class IIa regulatory treatment creates differentiation around clinical claims, quality systems and sponsor capability.
  • A new GE HealthCare infrared skin thermometer entry was added to the ARTG on 19 February 2025, illustrating continued supplier participation in professional infrared categories.
  • An Omron-manufactured infrared ear thermometer received an ARTG entry on 15 January 2026, indicating continued product refresh activity in high-value consumer and clinical ear thermometry.

Market Challenges

Regulatory and Product-Safety Compliance Burden

  • Medical devices must demonstrate conformity with applicable Essential Principles before supply, raising documentation, quality-assurance and sponsor costs relative to unregulated consumer electronics.
  • Australia introduced mandatory button and coin battery standards that took effect in 2022, adding enclosure, warning and packaging requirements for applicable home medical devices such as thermometers.
  • A thermometer importer received a AUD 13,320 infringement notice in 2020 over alleged unlawful importation of devices not included in the ARTG, demonstrating tangible compliance risk for distributors.

Heavy Import Dependence and Supplier Concentration

  • China supplied about USD 17.5 million in 2024, representing roughly 31% of reported import value and creating exposure to sourcing, freight and currency movements.
  • China accounted for approximately 2.94 million of 3.86 million imported units in 2024, indicating materially higher concentration by volume than by value.
  • Australian exports were only about USD 4.1 million in 2024, illustrating limited domestic manufacturing depth and restricted ability to offset external supply shocks.

Post-Pandemic Demand Volatility and Price Competition

  • The 2022-2023 import contraction was approximately 13.9%, forcing brands and distributors to manage pandemic-era inventories and recalibrate procurement toward recurring replacement demand.
  • Imports recovered by approximately 11.4% in value during 2024, showing that normalisation is uneven and requiring conservative inventory planning rather than extrapolation from short-term respiratory peaks.
  • China's average reported import value per unit was materially below several developed-country sources in 2024, intensifying price pressure on branded basic thermometers and shifting profit pools toward clinical functionality and differentiation.

Market Opportunities

Connected Thermometry and Hospital Workflow Integration

  • Suppliers can monetise connected thermometer modules, disposable sensors, software integration and recurring accessories across 293 emergency departments and broader hospital networks rather than relying solely on low-margin handheld devices.
  • Public hospitals delivered approximately 43.6 million non-admitted patient-care service events in 2024-25, creating high-frequency opportunities for integrated vital-sign measurement in outpatient settings.
  • Integrated thermometry must continue meeting medical-device conformity and ARTG requirements, making regulatory competence an entry barrier that can protect suppliers with validated systems and institutional service capability.

Aged-Care and Home-Monitoring Expansion

  • Older Australians grew 26% between 2017 and 2025, strengthening the investment case for simple, readable, rapid thermometers designed for caregivers and older users.
  • Primary-care utilisation is highest among older cohorts for several Medicare-supported services, creating opportunities for distributors to link thermometry with broader home-monitoring bundles and chronic-care devices.
  • Approximately 5,700 general practices supplied quality-improvement data nationally in 2025, illustrating the scale of community clinical infrastructure accessible through professional distribution channels.

Safety-Led Replacement and Portfolio Upgrading

  • Electronic and infrared products capture replacement demand as health systems move away from mercury-containing measuring devices, benefiting manufacturers with compliant digital alternatives.
  • Mandatory button-battery standards covering thermometers create opportunities for brands to differentiate around secure compartments, packaging and household safety rather than price alone.
  • New ARTG entries through 2025 and 2026 indicate ongoing portfolio renewal, supporting investment in better-designed ear, forehead and professional devices as older products reach replacement cycles.

CHAPTER 9 - Competitive Landscape

Competitive Landscape Overview

Competition is fragmented across global device manufacturers, consumer-health brands, Australian sponsors and distributors, with regulatory approval, pharmacy access, clinical procurement relationships, product accuracy and supply-chain resilience forming key entry barriers.

Market Share Distribution

Helen of Troy Limited
Omron Healthcare Co., Ltd.
Baxter International Inc.
Microlife AG

Top 5 Players

1
Helen of Troy Limited
!$*
2
Omron Healthcare Co., Ltd.
^&
3
Baxter International Inc.
#@
4
Microlife AG
$
5
Royal Philips
&@$
Combined Share$%

Market Dynamics

Local Players70%
Regional/Int'l30%

8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.

Company Profiles (Top 10 Players)
Company Name
Market Share
Headquarters
Founding Year
Core Market Focus
Helen of Troy Limited
-El Paso, United States1968Braun ThermoScan and Vicks consumer infrared and digital thermometry
Omron Healthcare Co., Ltd.
-Kyoto, Japan2003Digital, forehead and ear thermometers for home healthcare
Baxter International Inc.
-Deerfield, United States1931Welch Allyn professional thermometry and vital-sign systems
Microlife AG
-Widnau, Switzerland-Digital and infrared family-health thermometers
Royal Philips
-Amsterdam, Netherlands1891Professional patient monitoring, tympanic and temporal thermometry
GE HealthCare Technologies Inc.
-Chicago, United States2023Clinical infrared thermometry and patient-monitoring integration
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-Shenzhen, China1991Hospital monitoring and infrared ear thermometry
Oricom International Pty Ltd.
-Sydney, Australia-Consumer infrared thermometers and family-health monitoring
Masimo Corporation
-Irvine, United States1989Connected clinical monitoring and wireless temperature sensing
Cardinal Health, Inc.
-Dublin, Ohio, United States1971Clinical electronic thermometry, probes and hospital consumables

Cross Comparison Parameters

The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.

1

ARTG Portfolio Breadth

2

Australian Channel Coverage

3

Australia Thermometry Revenue Growth

4

Gross Margin on Thermometry Portfolio

Analysis Covered

Market Share Analysis:

Compares sector revenue positions across consumer and institutional thermometry channels.

Cross Comparison Matrix:

Benchmarks channel reach, registrations, pricing, service and growth performance consistently.

SWOT Analysis:

Assesses brand strength, compliance capability, sourcing resilience and innovation depth.

Pricing Strategy Analysis:

Evaluates retail price ladders, institutional contracts, bundles and channel margins.

Company Profiles:

Profiles ownership, product breadth, Australian presence, channels and strategic focus.

CHAPTER 10 - REPORT TOC

Table of Contents

89Pages
34Chapters
10Companies Profiled
7Segmentation Types
Phase 1

Market Assessment Phase

11

Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.

Phase 2

Go-To-Market Strategy Phase

15 chapters

Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.

Phase 3

Survey Phase

8 chapters

Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers.

Complete Report Coverage

201+ detailed sections covering every aspect of the market

143

Assessment Sections

58

Strategy Sections

CHAPTER 11 - Our Approach

Research Methodology

Desk Research

  • Medical thermometer import-flow assessment
  • ARTG device registration mapping
  • Hospital utilisation demand benchmarking
  • Retail thermometry portfolio assessment

Primary Research

  • Medical device commercial directors interviewed
  • Hospital procurement managers interviewed
  • Pharmacy category managers interviewed
  • Regulatory affairs managers interviewed

Validation and Triangulation

  • 340 respondents across value chain
  • Trade-to-retail value reconciliation performed
  • Clinical demand proxies cross-checked
  • Company portfolios regulator-verified independently

CHAPTER 12 - FAQ

FAQs

Still have questions?

Our research team is here to help you find the right solution

Contact Research Team

Want the full report and an analyst walkthrough?

Unlock the complete dataset, segmentation cuts, and competitive analysis—plus a discovery call that maps insights to your go-to-market priorities.

;Australia Medical Thermometer Market Share, Companies & Trends Report 2025-2031